Modular Medical Expands Executive Team with Appointment Of Lynn O’Connor Vos as New CEO
O'Connor Vos Brings Deep Experience in Market Development, Commercializing Products and Patient AdvocacySAN DIEGO, CA / ACCESSWIRE / August 16,...
Month: August 2021
4 Data Analytics Programs Healthcare Teams Should Look Into
In almost every aspect of modern life, data can serve as a great resource to make any and all processes...
Turning Point Therapeutics Initiates TRIDENT-2 Clinical Study Investigating Repotrectinib-Trametinib Combination in KRAS G12D Mutated Advanced Solid Tumors
SAN DIEGO, Aug. 16, 2021 (GLOBE NEWSWIRE) -- Turning Point Therapeutics, Inc. (NASDAQ: TPTX), a precision oncology company developing next-generation...
Forza Innovations Inc. Announces Manufacturing Agreement In Principle
CALGARY, Alberta , Aug. 16, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire – Forza Innovations Inc. (OTC Pink: FORZ) (the “Company”)...
Castellum, Inc. Announces the Acquisition of Specialty Systems, Inc. and Filing of Record Second Quarter Financial Results
Castellum, Inc. Announces the Acquisition of Specialty Systems, Inc. and Filing of Record Second Quarter Financial Results Castellum, Inc. (OTC:...
CohBar Appoints Carol Nast to Its Board of Directors
MENLO PARK, Calif., Aug. 16, 2021 (GLOBE NEWSWIRE) -- CohBar, Inc. (NASDAQ: CWBR), a clinical stage biotechnology company developing mitochondria...
ResMed Launches AirSense 11 PAP Series, Advancing Digital Health in Sleep Apnea Treatment
New digital features designed to make therapy setup and nightly use easier for patients, and help clinicians provide care more...
Galectin Therapeutics Reports Financial Results for the Quarter Ended June 30, 2021, and Provides Business Update
Considering options for a Combination Cancer Immunotherapy trial based on encouraging results of Phase 1b trial which strengthened the rationale...
Marrone Bio Innovations Collaborates with Terramera to Enhance Product Performance and Expedite Novel Product Development
Two global leaders in sustainable crop protection combine green technology and biological solutions to reduce agriculture’s environmental footprintDAVIS, Calif., Aug....
Carrick Therapeutics Receives FDA Fast Track Designations for Two Samuraciclib Combinations for the Treatment of HR+, HER2ꟷ Advanced Breast Cancer and Locally Advanced or Metastatic Triple Negative Breast Cancer
DUBLIN, Ireland and BOSTON, Aug. 16, 2021 (GLOBE NEWSWIRE) -- Carrick Therapeutics, an oncology-focused biopharmaceutical company discovering and developing highly...
Halberd’s Disease Elimination Technology R&D at Youngstown State University (YSU) Draws Attention of CBS Affiliate WKBN
Jackson Center, Pennsylvania--(Newsfile Corp. - August 16, 2021) - Halberd Corporation's (OTC Pink: HALB) research at Youngstown State University (YSU)...
Ciitizen to Launch Cures Gateway Enabling Health Information Exchanges to Effortlessly Comply with 21st Century Cures Act Information Blocking Rule
Rochester RHIO is the first HIE in the Ciitizen network to benefit from simplified process for sharing clinical data with...
LENSAR to Present at the H.C. Wainwright Ophthalmology Virtual Conference
ORLANDO, Fla.--(BUSINESS WIRE)--LENSAR, Inc. (Nasdaq: LNSR) (“LENSAR” or “the Company”), a global medical technology company focused on advanced femtosecond laser...
New Study Evaluates the Use of Masimo Bridge® As an Alternative to Opioids
IRVINE, Calif.--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) announced today the findings of a study published in the Journal of Pain & Relief...
Two-Thirds of Americans Have Had a Negative Health Care Experience, According to Accenture Research
Empathy and adopting appropriate digital technologies are key to improving care NEW YORK--(BUSINESS WIRE)--The U.S. healthcare industry could improve care...
LivaNova Announces Early Retirement of $450 Million Term Loan and Executes $125 Million Revolving Credit Facility
Announcement follows closing of underwritten offering of ordinary shares LONDON--(BUSINESS WIRE)--#cardiovascular--LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology and innovation company,...
Enlivex: After Review of Phase II Data, Israeli Ministry of Health Authorizes Initiation of a Multi-Center, Randomized Phase IIb Clinical Trial Evaluating Allocetra in Severe and Critical COVID-19 Patients
Nes Ziona, Israel, Aug. 15, 2021 (GLOBE NEWSWIRE) -- Enlivex Therapeutics Ltd. (Nasdaq: ENLV, the “Company”), a clinical-stage macrophage reprogramming...
XORTX Therapeutics Calls Special Meeting of Shareholders
CALGARY, Alberta, Aug. 13, 2021 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or the “Company”) (CSE: XRX) (OTCQB: XRTXF), a...
Biophytis Announces the Issue of 4,950,000 New Shares in a Capital Increase Reserved for NEGMA and the Performance of the Judgments of March 16, 2021 and July 16, 2021
PARIS and CAMBRIDGE, Mass., Aug. 13, 2021 (GLOBE NEWSWIRE) -- Biophytis SA (NasdaqCM: BPTS, Euronext Growth Paris: ALBPS), (“Biophytis” or...
Entera Bio to Report Business and Financial Results for the Quarter ended June 30, 2021, on August 16, 2021
BOSTON and JERUSALEM, Aug. 13, 2021 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ: ENTX), a leader in the development of...